4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000122
Chief Legal Officer sold 5,760 shares at an average $22.23 ($128,017)
- Chief Legal Officer acquired 5,760 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,760 | $1.86 | $10,714 | 30,352 | D |
| 2024-10-01 | Sale : show line 2 in the form 10b5-1 | −5,460 | $22.19 | $121,174 | 24,892 | D |
| 2024-10-01 | Sale : show line 3 in the form 10b5-1 | −300 | $22.81 | $6,843 | 24,592 | D |
| Open-market sales · 5,760 sh · avg $22.23 · $128,017 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-01 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (right to buy) | −5,760 | 71,266 | D |
Loading xslF345X05/wk-form4_1727825780.xml…